Select Page
University of Manchester team develops graphene-based antibody test for detection of kidney disease

University of Manchester team develops graphene-based antibody test for detection of kidney disease

An interdisciplinary team of researchers from The University of Manchester have developed a new graphene-based testing system for disease-related antibodies, initially targeting a kidney disease called Membranous Nephropathy.The new instrument, based on the principle...
Research team develops new method to generate  precisely controlled graphene microbubbles

Research team develops new method to generate precisely controlled graphene microbubbles

Researchers at Swinburne University of Technology recently teamed up with teams from National University of Singapore, Rutgers University, University of Melbourne, and Monash University, to develop a method to generate precisely controlled graphene microbubbles on a...

Caltech team develops sensor that rapidly detects COVID-19 infection

Caltech researchers have developed a new type of multiplexed test (a test that combines multiple kinds of data) with a low-cost sensor that may enable the at-home diagnosis of a COVID infection through rapid analysis of small volumes of saliva or blood, without the...

Edmonton Airport to host trial of new graphene-based COVID-19 testing technology

It was recently reported that Edmonton International Airport (YEG) will host a trial for a new graphene-based COVID-19 testing technology that can produce results in seconds. The trials will be executed in partnership with GLC Medical, a subsidiary of Graphene Leaders...
ZEN Graphene Solutions develops a graphene-based ink with 99% virucidal activity against COVID-19

ZEN Graphene Solutions develops a graphene-based ink with 99% virucidal activity against COVID-19

ZEN Graphene Solutions has reported that it has developed a novel graphene-based virucidal ink with 99% effectiveness against COVID-19. ZEN’s Virucidal ink was reportedly also 99% effective a minimum of 35 days after application to N95 mask material. ZEN is now...

Cardea Bio raises $7.5 million in series A2 financing

Following a $7.8 Million Series A-1 financing announced in March 2019, Cardea, (formerly called Nanomedical Diagnostics), a U.S-based manufacturer of a biology-enabled transistor technology made from graphene-based biosensors, now announced another $7.5 Million raised...